Trivascular Technologies Quick Ratio (TRIV) starting from the third quarter 2015 to third quarter 2014, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Trivascular Technologies, Inc.  (TRIV)

Trivascular Technologies's Quick Ratio

TRIV's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Current Liabilities decreased faster than Trivascular Technologies's Cash & cash equivalent, this led to improvement in Trivascular Technologies's Quick Ratio to 18, Quick Ratio remained below Trivascular Technologies, Inc. average.

Within Medical Equipment & Supplies industry Trivascular Technologies, Inc. booked the highest Quick Ratio than Trivascular Technologies in the third quarter 2015. While Quick Ratio total ranking has improved so far during the Q3 2015 to 211, from total ranking in the second quarter 2015 at 215.

Explain Quick Ratio?
How much Cash & cash equivalents TRIV´s has?
What are TRIV´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

TRIV Quick Ratio (Sep 30 2015)
Q3		 (Jun 30 2015)
Q2		 (Mar 31 2015)
Q1		 (Dec 31 2014)
Q4		 (Sep 30 2014)
Q3
Y / Y Current Liabilities Change 56.36 % -65.92 % -51.46 % -80.16 % -
Y / Y Cash & cash equivalent Change -39.76 % -44.89 % 110.79 % 107.25 % -
Quick Ratio MRQ 18 17.75 17.92 42.42 46.71
TRIV's Total Ranking # 211 # 215 # 218 # 80 # 71
Seq. Current Liabilities Change -6.4 % -19.62 % 98.44 % 4.72 % -79.6 %
Seq. Cash & cash equivalent Change -5.09 % -20.38 % -16.17 % -4.89 % -13.18 %



Quick Ratio third quarter 2015 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 1
Healthcare Sector # 71
Overall Market # 211


Quick Ratio Statistics
High Average Low
46.71 20.24 4.06
(Sep 30 2014)   (Dec 31 2013)




Financial Statements
Trivascular Technologies's Current Liabilities $ 3 Millions Visit TRIV's Balance sheet
Trivascular Technologies's Cash & cash equivalent $ 50 Millions Visit TRIV's Balance sheet
Source of TRIV's Sales Visit TRIV's Sales by Geography


Cumulative Trivascular Technologies's Quick Ratio

TRIV's Quick Ratio for the trailling 12 Months

TRIV Quick Ratio

 (Sep 30 2015)
12 Months		 (Jun 30 2015)
12 Months		 (Mar 31 2015)
12 Months		 (Dec 31 2014)
12 Months		 (Sep 30 2014)
12 Months
Y / Y Current Liabilities TTM Growth -58.87 % -59.93 % -5.58 % 112.75 % -
Y / Y Cash & cash equivalent TTM Growth -0.12 % 70.09 % 365.91 % 658.61 % -
Quick Ratio TTM 21.93 27.26 20.18 14.48 9.03
Total Ranking TTM # 208 # 209 # 209 # 207 # 3442
Seq. Current Liabilities TTM Growth 9.72 % -35.8 % -19.62 % -27.37 % 6.91 %
Seq. Cash & cash equivalent TTM Growth -11.75 % -13.26 % 12.04 % 16.47 % 50.28 %

Quick ratio ranking by company, industry and sector >> Back to TRIV Financial Strength Comparisons >> Go to Compare TRIV Quick Ratio to its Competitors

On the trailing twelve months basis Due to decrease in Current Liabilities in the Q3 2015 to $2.78 millions, cumulative Quick Ratio decreased to 21.93 above the TRIV average Quick Ratio.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 9 other companies have achieved higher Quick Ratio than Trivascular Technologies. While Quick Ratio overall ranking has improved so far to 208, from total ranking during the twelve months ending second quarter 2015 at 209.

Explain Quick Ratio?
How much Cash & cash equivalents TRIV´s has?
What are TRIV´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 10
Healthcare Sector # 78
Within the Market # 208


trailing twelve months Quick Ratio Statistics
High Average Low
6.04 6.04 6.04
(Sep. 30, 2015)  




Companies with similar Quick Ratio in the quarter ending Sep 30 2015, within Medical Equipment & Supplies Industry Quick RatioSep 30 2015 MRQ Cash & cash equivalentSep 30 2015 MRQ Current Liabilities
Bone Biologics Corporation  36.53 $ 2.126  Millions$ 0.058  Millions
Trivascular Technologies, Inc.  18.00 $ 50.029  Millions$ 2.780  Millions
Perspective Therapeutics Inc   14.47 $ 13.478  Millions$ 0.931  Millions
Presbia Plc  12.39 $ 25.371  Millions$ 2.048  Millions
Surmodics Inc   11.83 $ 55.588  Millions$ 4.700  Millions
Owc Pharmaceutical Research Corp.  11.20 $ 0.532  Millions$ 0.048  Millions
Icu Medical Inc  10.59 $ 394.063  Millions$ 37.203  Millions
Conformis inc   10.39 $ 139.202  Millions$ 13.396  Millions
Anika Therapeutics Inc   9.85 $ 130.476  Millions$ 13.245  Millions
Intersect Ent Inc   9.80 $ 131.052  Millions$ 13.368  Millions
Nevro Corp   9.47 $ 222.552  Millions$ 23.496  Millions
Avinger Inc   9.28 $ 54.781  Millions$ 5.900  Millions
Iradimed Corporation  8.77 $ 23.420  Millions$ 2.671  Millions
Envue Medical Inc   7.39 $ 1.994  Millions$ 0.270  Millions
Axogen inc   7.30 $ 29.935  Millions$ 4.100  Millions
Corindus Vascular Robotics, Inc.  7.11 $ 50.494  Millions$ 7.100  Millions
Eternity Healthcare Inc.  7.04 $ 1.020  Millions$ 0.145  Millions
Penumbra Inc  5.63 $ 159.098  Millions$ 28.277  Millions
Resmed Inc   5.53 $ 822.053  Millions$ 148.539  Millions
Apollo Endosurgery inc   5.44 $ 11.554  Millions$ 2.125  Millions
Cerus Corporation  5.39 $ 107.447  Millions$ 19.918  Millions
Novocure Limited  5.30 $ 137.323  Millions$ 25.915  Millions
Insulet Corporation  5.26 $ 145.467  Millions$ 27.644  Millions
Gi Dynamics Inc   5.19 $ 24.439  Millions$ 4.709  Millions
Aethlon Medical Inc   5.10 $ 4.227  Millions$ 0.829  Millions
Abiomed Inc   5.09 $ 175.508  Millions$ 34.452  Millions
Luminex Corporation  4.93 $ 131.559  Millions$ 26.661  Millions
Glaukos Corp  4.75 $ 93.419  Millions$ 19.677  Millions
T2 Biosystems Inc   4.75 $ 40.117  Millions$ 8.454  Millions
Antares Pharma Inc   4.73 $ 47.890  Millions$ 10.119  Millions

Date modified: 2026-09-08T15:07:59+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.